| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |